Kayne Anderson Rudnick Investment Management
REGN icon

Kayne Anderson Rudnick Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.75M Sell
9,223
-461
-5% -$314K 0.02% 268
2026
Q1 		$7.48M Buy
9,684
+328
+4% +$251K 0.02% 242
2025
Q4 		$7.22M Buy
9,356
+69
+0.7% +$46.9K 0.02% 246
2025
Q3 		$5.22M Buy
9,287
+317
+4% +$179K 0.01% 266
2025
Q2 		$4.71M Buy
8,970
+404
+5% +$225K 0.01% 266
2025
Q1 		$5.43M Buy
8,566
+3,288
+62% +$2.26M 0.01% 267
2024
Q4 		$3.76M Sell
5,278
-468
-8% -$393K 0.01% 288
2024
Q3 		$6.04M Buy
5,746
+89
+2% +$99K 0.01% 263
2024
Q2 		$5.95M Buy
5,657
+1,263
+29% +$1.22M 0.01% 271
2024
Q1 		$4.23M Buy
4,394
+280
+7% +$266K 0.01% 298
2023
Q4 		$3.61M Sell
4,114
-156
-4% -$128K 0.01% 307
2023
Q3 		$3.51M Sell
4,270
-32
-0.7% -$25.1K 0.01% 313
2023
Q2 		$3.09M Buy
+4,302
New +$3.32M 0.01% 322
2022
Q2 		– Sell
-3
Closed -$2K – 668
2022
Q1 		$2K Buy
+3
New +$1.9K ﹤0.01% 601
2020
Q3 		– Sell
-7
Closed -$4K – 576
2020
Q2 		$4K Hold
7
– – ﹤0.01% 472
2020
Q1 		$3K Sell
7
-4
-36% -$1.65K ﹤0.01% 500
2019
Q4 		$4K Buy
11
+4
+57% +$1.35K ﹤0.01% 493
2019
Q3 		$2K Hold
7
– – ﹤0.01% 522
2019
Q2 		$2K Buy
+7
New +$2.33K ﹤0.01% 512

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's REGN Position: Q2 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its Regeneron Pharmaceuticals (REGN) stake by 4.8% in Q2 2026, selling an estimated $314K and leaving 9,223 shares worth $5.75M. The position accounts for 0.02% of the portfolio, ranked #268.

Kayne Anderson Rudnick Investment Management first reported a position in REGN in Q2 2019 and has held it in 19 quarters since. The position peaked at $7.48M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Kayne Anderson Rudnick Investment Management held 9,223 shares of Regeneron Pharmaceuticals worth $5.75M as of Q2 2026.
  • Kayne Anderson Rudnick Investment Management sold 461 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $314K.
  • Regeneron Pharmaceuticals made up 0.02% of Kayne Anderson Rudnick Investment Management's portfolio in Q2 2026, its #268 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2019 and has held it in 19 quarters since.
  • Kayne Anderson Rudnick Investment Management's Regeneron Pharmaceuticals position peaked at $7.48M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.